SevenBridge Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

SevenBridge Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-125	Closed	-$1K	–	528
2019 Q2	$1K	Hold	125	–	–	﹤0.01%	623
2019 Q1	$2K	Hold	125	–	–	﹤0.01%	567
2018 Q4	$2K	Hold	125	–	–	﹤0.01%	528
2018 Q3	$3K	Hold	125	–	–	﹤0.01%	535
2018 Q2	$3K	Hold	125	–	–	﹤0.01%	540
2018 Q1	$2K	Hold	125	–	–	﹤0.01%	574
2017 Q4	$2K	Hold	125	–	–	﹤0.01%	586
2017 Q3	$2K	Hold	125	–	–	﹤0.01%	578
2017 Q2	$4K	Hold	125	–	–	﹤0.01%	553
2017 Q1	$4K	Sell	125 -4,599	-97%	-$157K	﹤0.01%	536
2016 Q4	$209K	Hold	4,724	–	–	0.15%	126
2016 Q3	$209K	Buy	4,724 +1,550	+49%	+$80.9K	0.15%	126
2016 Q2	$159K	Buy	+3,174	New	+$169K	0.11%	158

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

SevenBridge Financial Group's TEVA Position: Q3 2019 in Review

SevenBridge Financial Group sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 125 shares — an estimated $1K sold.

SevenBridge Financial Group first reported a position in TEVA in Q2 2016 and held it in 13 quarters. The position peaked at $209K in Q4 2016. 427 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

SevenBridge Financial Group reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
SevenBridge Financial Group sold 125 Teva Pharmaceuticals shares in Q3 2019, an estimated $1K.
SevenBridge Financial Group first reported a position in Teva Pharmaceuticals in Q2 2016 and held it in 13 quarters.
SevenBridge Financial Group's Teva Pharmaceuticals position peaked at $209K in Q4 2016.
427 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on SevenBridge Financial Group's 13F filing for Q3 2019, filed 9 Oct 2019.